New Edge Advisors, LLC Codexis, Inc. Transaction History

New Edge Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $5,831 - $9,363	1,369 New	1,369 $6,000
Q2 2022 Aug 09, 2022	BUY	$8.35 - $21.89 $264,252 - $692,752	31,647 Added 75.21%	73,727 $771,000
Q1 2022 May 13, 2022	BUY	$16.97 - $31.93 $73,887 - $139,023	4,354 Added 11.54%	42,080 $868,000
Q4 2021 Feb 17, 2022	BUY	$25.61 - $41.78 $116,371 - $189,848	4,544 Added 13.69%	37,726 $1.18 Million
Q3 2021 Oct 29, 2021	SELL	$19.65 - $27.99 $145,567 - $207,349	-7,408 Reduced 18.25%	33,182 $772,000
Q2 2021 Jul 22, 2021	BUY	$17.48 - $25.46 $709,513 - $1.03 Million	40,590 New	40,590 $920,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.